Biotech CEO had known about researcher's criminal past for years before "shock" revelation

The Enochian CEO claimed he was ”shocked” by the scientist’s past in 2022, despite the fact he was told about potentially lethal treatments in 2019. He says all material information was disclosed.
In the winter of 2019, Enochian Biosciences CEO Mark Dybul received an email including court documents outlining potentially lethal cancer treatments administered by the company's star scientist – a few years later he was "shocked" when stock market researchers described similar behavior. | Photo: Genereret af DALL·E
In the winter of 2019, Enochian Biosciences CEO Mark Dybul received an email including court documents outlining potentially lethal cancer treatments administered by the company's star scientist – a few years later he was "shocked" when stock market researchers described similar behavior. | Photo: Genereret af DALL·E

It was presented as a bolt from the blue.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Foto: Mike Blake/Reuters/Ritzau Scanpix

    Gilead Sciences CMO to leave early 2025

    For subscribers

    Further reading